The polypyrimidine tract binding protein (PTB) and its recently discovered homologue brain-enriched PTB (brPTB) are RNA binding proteins involved in the control of alternative splicing. We have characterized expression patterns of the PTB and brPTB in course of mouse brain development, using mRNA in situ hybridization. PTB is expressed in choroid plexi and ependyma at all the stages of development and temporarily in the mantle layer of migrating neuroblasts of fore-, mid-and hindbrain and in the external granular layer of cerebellum. In the neurons of adult mouse cerebrum and cerebellum expression of PTB is undetectable. In contrast to this, brPTB is expressed ubiquitously in neuroblasts of various parts of embryonic brain and in the differentiated neurons of postnatal cerebrum and cerebellum. brPTB mRNA is not observed in choroid plexi and ependymal layer. Thus, in the embryonic brain expression patterns of PTB and brPTB overlap, but in the course of brain development the patterns become complementary to each other. q
Results
The polypyrimidine tract binding protein (PTB) belongs to the hnRNP family and its role in the regulation of splicing of a wide spectrum of pre-mRNA targets (including neuronspeci®c splicing events) has been studied extensively (Mulligan et al., 1992; Zhang et al., 1999; Southby et al., 1999; Chou et al., 2000) . A novel neural homologue of PTB exhibiting 70% identity at amino acid sequence level, and overall similarity in structure with four conserved RRM motifs, was discovered by our group during the search for proteins binding to a caspase (O È rd et al., manuscript in preparation) . Recently Polydorides et al. (2000) have reported about cloning of the same protein, giving it the name brain-enriched PTB (brPTB), and described its interaction with the splicing factor Nova.
While brPTB mRNA is synthesized at a high level in adult mouse brain and testis and much less in other tissues, the PTB mRNA is present in a wide variety of tissues (Fig.  1) . We have carried out developmental characterization of the expression patterns of the PTB and brPTB genes in the mouse brain, using mRNA in situ hybridization. Whole-mount mouse embryo (E11.5) hybridization to PTB probe reveals that the gene is expressed in various parts of the body, including the developing brain (Fig. 2) . The signal is clearly visible in the forebrain, and slightly weaker in the mid-and hindbrain.
The expression of brPTB in the mouse embryo of the same age is almost restricted to the brain, showing a strong signal in the fore-, mid-and hindbrain (Fig. 2) .
Sections made from 1 day older embryo (E12.5) con®rm PTB expression in the fore-and midbrain and in the rostral part of the hindbrain (Fig. 3A) . The PTB hybridization signal surrounds the ventricles predominantly, and can be clearly distinguished in the epithelium of the developing choroid plexi (Fig. 3C ) and in the migrating neuroblasts of the mantle layer, but it is missing in most of the remainder developing neural tissue. Conversely to this, brPTB is expressed not only in ventricular and subventricular zones, but throughout the whole fore-, mid-and hindbrain (Fig. 3B) . However, the brPTB signal is undetectable in the choroid plexus and its epithelium (Fig. 3D ).
In the neonatal (P1) and 1 week old (P7) mouse brain PTB is expressed in three major areas: in ependyma, choroid plexi and especially intensively in the external layer of gran- (Fig. 4E ) and in the vicinity of hippocampus (Fig. 4A ) also give a positive signal, but no PTB expression can be detected in the rest of the brain tissue (Figs. 4C and 5A,E) . In the brain of older mouse (P14, P21, P60) the expression signal is not observed in the neurons of cerebrum (data not shown) and cerebellum (Fig. 6B) . The signal is retained in the ependymal layer and choroid plexi (Fig. 6A) , but it appears to be weaker in comparison with the neonatal brain.
While PTB expression in P1 and P7 brain is restricted to speci®c areas mentioned above, the brPTB expression at the same age is extensive, covering almost the whole brain tissue (Figs. 4B,D,F and 5C ,G,J). However, brPTB is not expressed in the ependyma and ventricular choroid plexi (Figs. 4B,D and 5G,H) . The brPTB expression pattern in the brain of the older mouse (P14, P21, P60) is similar to the early postnatal one, showing a strong signal in the cerebral cortex (Fig. 6E,F ) and hippocampus and no signal in the ependymal layer and choroid plexi (Fig. 6C,D) .
To characterize the type of the cells expressing PTB and brPTB, the antibodies recognizing glial ®brillary acidic protein (GFAP) and neuro®lament protein (NF) were used. The brPTB expression signal colocalizes with the neuron-speci®c marker NF (Fig. 6F) . At the same time, no PTB and brPTB expression was detectable in glial cells labeled by anti-GFAP antibody (Fig. 5B,D,I,J) , except the ependymal cells that were positive for PTB.
On the basis of the current results a speci®c temporal character of the PTB expression can be outlined. The PTB mRNA is synthesized predominantly in the immature developing neural tissue. Concurrently with brain maturation the expression of PTB in the neural tissue decreases and it is maintained in adult mouse brain only in the ependyma surrounding the ventriculi and in the choroid plexi located inside the latter structures.
Conversely, no major changes of brPTB expression level occur during the course of brain development. brPTB is expressed at a high level both in developing neural tissue as well as in mature differentiated neurons. brPTB mRNA is undetectable in the ependyma and the choroid plexi at all stages of brain development from E12.5 to maturity.
Methods
Mouse multiple tissue Northern blot was purchased from Clontech (USA) and analyzed according to manufacturer's instructions. A 1.3 kb fragment from coding region of mouse brPTB cDNA (cloned by our group) and a 1 kb fragment from coding region of mouse PTB cDNA (originating from I.M.A.G.E. EST clone No. 480448) were used as brPTB and PTB probes, respectively. In situ hybridizations with digoxigenin-labeled antisense and sense (control) riboprobes were done as described (Wilkinson, 1992; Wilkinson and Nieto, 1993) . Visualization was carried out by alkaline phosphatase-coupled anti-digoxigenin antibody (Roche Molecular Biochemicals) and NBT/BCIP, and sections were counterstained with Nuclear Fast Red (DAKO). Immunohistochemical analysis was performed using monoclonal anti-GFAP antibody (clone 6F2; DAKO), monoclonal anti-NF antibody (clone 2F11; DAKO), StreptABComplex/HRP Duet Mouse/Rabbit (DAKO) and 3,3-diaminobenzidine as a chromogen. 
